ArticleEuropean journal of orthopaedic surgery & traumatology : orthopedie traumatologie2025
Patients' quality of life and function evaluation after successful management of infected segmental bone defects with the induced membrane technique.
Article in European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bone transport in the management of fracture-related infection: current concepts and innovations.Journal of bone and joint infection · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThis study aimed to evaluate the health perception of quality of life and function in patients with segmental bone defects (SBD) of the femur or tibia treated with the Induced Membrane Technique (IMT) and achieved bone healing and infection control.
methodsThis cross-sectional cohort study was conducted at a single referral center. Patients with infected SBD of the femur or tibia treated with IMT were included if they had at least 12 months of bone healing and no evidence of infection. Three questionnaires were administered: the EuroQol five-dimensional questionnaire (EQ-5D), the short form 36 (SF-36), and the lower extremity functional score (LEFS).
resultsThe final cohort consisted of 33 patients, with a mean age of 39 ± 16.7 years. Twenty defects involved the tibia. The average bone defect measured 6 cm (range 3.5-12). The median healing time was 7.4 months (range 3-14), with 30 patients (90.9%) achieving healing without reoperation. The average follow-up period from the second stage was 46 months (range 20-85). Questionnaires were completed on average at 30 months (range 15-70) after bone healing was recorded. The mean EQ-5D VAS score was 63.63 ± 13.20, and the EQ-5D index was 0.72 ± 0.26. In the SF-36, the mean MCS was 52.8 ± 3.2, and the PCS was 46.45 ± 3.9. The mean LEFS score was 65 ± 4.8, with a range of 55 to 73. Overall, out of the 5, the EQ-5D mobility and pain/discomfort had the lowest scores, whereas in the LEFS, the items indicating limitations required greater physical demand, such as walking more than a mile, running, and jumping.
conclusionDespite successful bone healing and infection control with the IMT, patients with infected femoral or tibial SBD continue to experience an impaired quality of life more than 2 years after treatment. Although functional and mental scores were relatively acceptable, patients reported physical limitations and discomfort with certain tasks, highlighting ongoing challenges in their physical recovery.
Indexed as
Identifiers
40925938What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.